Kubient (KBNT) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsOptions ChainSEC FilingsTrendsBuy This Stock KBNT vs. KLDO, ALFIW, APCXW, ARBEW, AOGOW, AOGOU, AUROW, AVPTW, BNIXW, and BNIXRShould you be buying Kubient stock or one of its competitors? The main competitors of Kubient include Kaleido Biosciences (KLDO), Alfi (ALFIW), AppTech Payments (APCXW), Arbe Robotics (ARBEW), Arogo Capital Acquisition (AOGOW), Arogo Capital Acquisition (AOGOU), Aurora Innovation (AUROW), AvePoint (AVPTW), Bannix Acquisition (BNIXW), and Bannix Acquisition (BNIXR). These companies are all part of the "computer software" industry. Kubient vs. Kaleido Biosciences Alfi AppTech Payments Arbe Robotics Arogo Capital Acquisition Arogo Capital Acquisition Aurora Innovation AvePoint Bannix Acquisition Bannix Acquisition Kaleido Biosciences (NASDAQ:KLDO) and Kubient (NASDAQ:KBNT) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation, community ranking and institutional ownership. Is KLDO or KBNT more profitable? Company Net Margins Return on Equity Return on Assets Kaleido BiosciencesN/A N/A N/A Kubient N/A N/A N/A Does the media favor KLDO or KBNT? In the previous week, Kaleido Biosciences' average media sentiment score of 0.00 equaled Kubient'saverage media sentiment score. Company Overall Sentiment Kaleido Biosciences Neutral Kubient Neutral Do insiders & institutionals hold more shares of KLDO or KBNT? 81.6% of Kaleido Biosciences shares are held by institutional investors. Comparatively, 13.9% of Kubient shares are held by institutional investors. 9.0% of Kaleido Biosciences shares are held by insiders. Comparatively, 22.3% of Kubient shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community believe in KLDO or KBNT? Kaleido Biosciences received 49 more outperform votes than Kubient when rated by MarketBeat users. However, 71.43% of users gave Kubient an outperform vote while only 57.45% of users gave Kaleido Biosciences an outperform vote. CompanyUnderperformOutperformKaleido BiosciencesOutperform Votes5457.45% Underperform Votes4042.55% KubientOutperform Votes571.43% Underperform Votes228.57% Which has more risk & volatility, KLDO or KBNT? Kaleido Biosciences has a beta of -0.06, suggesting that its stock price is 106% less volatile than the S&P 500. Comparatively, Kubient has a beta of 1.13, suggesting that its stock price is 13% more volatile than the S&P 500. Which has stronger earnings & valuation, KLDO or KBNT? Kubient has higher revenue and earnings than Kaleido Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKaleido Biosciences$1.10M0.04-$95.48M-$2.240.00Kubient$1.17M0.00-$13.62MN/AN/A SummaryKubient beats Kaleido Biosciences on 5 of the 7 factors compared between the two stocks. Remove Ads Get Kubient News Delivered to You Automatically Sign up to receive the latest news and ratings for KBNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KBNT vs. The Competition Export to ExcelMetricKubientComputer integrated systems design IndustryBusiness SectorNASDAQ ExchangeMarket Cap$1,000.00$3.40B$7.03B$7.68BDividend YieldN/A2.20%2.53%4.02%P/E RatioN/A60.4329.4918.55Price / SalesN/A23.56143.3588.66Price / CashN/A34.8531.4034.64Price / BookN/A4.684.604.11Net Income-$13.62M$38.20M$195.05M$247.18M Kubient Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KBNTKubientN/AN/AN/AN/A$1,000.00$1.17M0.0040KLDOKaleido BiosciencesN/A$0.00flatN/AN/A$4,000.00$1.10M0.0080ALFIWAlfiN/AN/AN/AN/A$0.00$200,684.000.0040APCXWAppTech PaymentsN/A$0.19+25.0%N/A-42.4%$0.00$365,000.000.0020ARBEWArbe RoboticsN/A$0.27-2.6%N/A+25.4%$0.00$768,000.000.00120Short Interest ↑Positive NewsAOGOWArogo Capital AcquisitionN/A$0.03-71.0%N/AN/A$0.00N/A0.00N/AAOGOUArogo Capital AcquisitionN/A$8.50flatN/AN/A$0.00N/A0.00N/AAUROWAurora InnovationN/A$1.63+9.9%N/A+429.6%$0.00$2M0.001,700Short Interest ↑Gap UpAVPTWAvePointN/A$5.11+8.3%N/A+373.0%$0.00$330.48M0.001,930Gap UpBNIXWBannix AcquisitionN/A$0.02flatN/AN/A$0.00N/A0.003BNIXRBannix AcquisitionN/A$0.14+24.4%N/AN/A$0.00N/A0.003Gap Up Remove Ads Related Companies and Tools Related Companies Kaleido Biosciences Alternatives Alfi Alternatives AppTech Payments Alternatives Arbe Robotics Alternatives Arogo Capital Acquisition Alternatives Arogo Capital Acquisition Alternatives Aurora Innovation Alternatives AvePoint Alternatives Bannix Acquisition Alternatives Bannix Acquisition Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KBNT) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kubient, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kubient With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
